Interferon beta-1b

Interferon beta-1b
Clinical data
Trade names	Betaseron, Actoferon, Extavia
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a601151
License data	EU EMA: by INN; US DailyMed: Interferon_beta-1b;
Routes of; administration	Subcutaneous
ATC code	L03AB08 (WHO) ;
Legal status
Legal status	US: ℞-only; EU: Rx-only; In general: ℞ (Prescription only);
Identifiers
	IUPAC name Human interferon beta;
CAS Number	145155-23-3 ;
IUPHAR/BPS	8340;
DrugBank	DB00068 ;
ChemSpider	none;
UNII	TTD90R31WZ;
KEGG	D00746 ;
ChEMBL	ChEMBL1201563 ;
ECHA InfoCard	100.207.515
Chemical and physical data
Formula	C908H1408N246O253S6
Molar mass	20011.08 g·mol−1
	(what is this?) (verify)

Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.